Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Catechol-O-methyltransferase rs4680 and rs4818 haplotype association with treatment response to olanzapine in patients with schizophrenia
Matea Nikolac Perković, Marina Šagud, Maja Živković, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 19

Showing 19 citing articles:

Emerging evidence for astrocyte dysfunction in schizophrenia
Eva Cristina de Oliveira Figueiredo, Corrado Calì, Francesco Petrelli, et al.
Glia (2022) Vol. 70, Iss. 9, pp. 1585-1604
Open Access | Times Cited: 51
From genes to drugs: CYP2C19 and pharmacogenetics in clinical practice
Qamar Shubbar, Aminah Alchakee, Khaled Walid Issa, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 7
Insights into S-adenosyl-l-methionine (SAM)-dependent methyltransferase related diseases and genetic polymorphisms
Jiaojiao Li, Chunxiao Sun, Wenwen Cai, et al.
Mutation Research/Reviews in Mutation Research (2021) Vol. 788, pp. 108396-108396
Open Access | Times Cited: 35
Pharmacogenetics of obsessive-compulsive disorder: Investigations of intragenic and regulatory region genetic variations
Gwyneth Zai, Clement C. Zai, Vanessa F. Gonçalves, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111315-111315
Closed Access
The Associations between COMT and MAO-B Genetic Variants with Negative Symptoms in Patients with Schizophrenia
Zoran Madžarac, Lucija Tudor, Marina Šagud, et al.
Current Issues in Molecular Biology (2021) Vol. 43, Iss. 2, pp. 618-636
Open Access | Times Cited: 22
Effect of Catechol-O-Methyltransferase Genotype Polymorphism on Neurological and Psychiatric Disorders: Progressing Towards Personalized Medicine
Kosha Srivastava, Olive Ochuba, Jasmine K Sandhu, et al.
Cureus (2021)
Open Access | Times Cited: 13
Search for Association of Polymorphisms rs6280 of the DRD3 Gene, rs4680 of the COMT Gene, rs6265 of the Gene BDNF with Schizophrenia Resistant to Antipsychotic Therapy in Russian Populations
M. A. Kaydan, Natalia V. Zakharova, Yana Zorkina, et al.
Psikhiatriya (2024) Vol. 21, Iss. 7, pp. 14-23
Open Access | Times Cited: 1
Variants in COMT, CYP3A5, CYP2B6, and ABCG2 Alter Quetiapine Pharmacokinetics
Pablo Zubiaur, Paula Fernández-Campos, Marcos Navares‐Gómez, et al.
Pharmaceutics (2021) Vol. 13, Iss. 10, pp. 1573-1573
Open Access | Times Cited: 8
Genetic variants of ZNF385B and COMT are associated with autism spectrum disorder in the Bangladeshi children
Md. Giash Uddin, Shafayet Ahmed Siddiqui, Mohammad Sarowar Uddin, et al.
Meta Gene (2020) Vol. 26, pp. 100820-100820
Closed Access | Times Cited: 7
Genotypic and Haplotypic Association of Catechol-O-Methyltransferase rs4680 and rs4818 Gene Polymorphisms with Particular Clinical Symptoms in Schizophrenia
Marina Šagud, Lucija Tudor, Gordana Nedić Erjavec, et al.
Genes (2023) Vol. 14, Iss. 7, pp. 1358-1358
Open Access | Times Cited: 2
A preliminary study on the association of single nucleotide polymorphisms and methylation of dopamine system‐related genes with psychotic symptoms in patients with methamphetamine use disorder
Ting Fang, Mengnan Liu, Mengqi Liu, et al.
European Journal of Neuroscience (2023) Vol. 59, Iss. 7, pp. 1428-1440
Closed Access | Times Cited: 2
Clinical Utility and Implementation of Pharmacogenomics for the Personalisation of Antipsychotic Treatments
Marta Hernández, Natàlia Cullell, Marc Cendrós, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 244-244
Open Access
COMT and Neuregulin 1 Markers for Personalized Treatment of Schizophrenia Spectrum Disorders Treated with Risperidone Monotherapy
Mariana Bondrescu, Liana Dehelean, Simona Sorina Farcaş, et al.
Biomolecules (2024) Vol. 14, Iss. 7, pp. 777-777
Open Access
The moderating role of COMT gene rs4680 polymorphism between maladaptive metacognitive beliefs and negative symptoms in patients with schizophrenia
Feten Fekih-Romdhane, Georges Kerbage, Nagham Hachem, et al.
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access
COMT rs4818 less common allele is associated with psychological and psychiatric worse indicators in a cohort of individuals born with cleft lip and palate
Alexandre R. Vieira, Mariana Silva Barros, Maria Sueli Marqués Soares, et al.
Orthodontics and Craniofacial Research (2022) Vol. 26, Iss. 3, pp. 387-392
Closed Access | Times Cited: 1
Catechol-O-methyltransferase (COMT) Val158Met polymorphism in schizophrenia patients: response to antipsychotic treatment and cognitive function
Saidah Syamsuddin, Tri Rakhmawati, Erlyn Limoa, et al.
Journal of Population Therapeutics and Clinical Pharmacology (2023) Vol. 30, Iss. 16
Open Access
Genetic Polymorphism as a Possible Cause of Severe Postoperative Pain
Bart Govers, Maja Matić, Ron H. N. van Schaik, et al.
The Journal of Clinical Pharmacology (2023) Vol. 64, Iss. 3, pp. 378-381
Open Access
Zavod za kliničku psihijatriju: jučer, danas i sutra
Marina Šagud, Alma Mihaljević-Peleš, Bjanka Vuksan Ćusa, et al.
Socijalna psihijatrija (2022) Vol. 50, Iss. 2, pp. 110-126
Open Access
Zavod za kliničku psihijatriju: jučer, danas i sutra
Marina Šagud, Alma Mihaljević-Peleš, Bjanka Vuksan Ćusa, et al.
Socijalna psihijatrija (2022) Vol. 50, Iss. 2, pp. 110-126
Open Access
Page 1

Scroll to top